|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | CA 2020 00062, 20201222 | | Patent/reg. no. and date | CR 2020 00062 | | Publication date | | | Priority no. and date | | | EP pub. no. and date | | | Effective date | | | Applicant/owner | Merck Patent GmbH, Frankfurter Strasse 250
64293 Darmstadt, DE | | Applicant ref. no. | 75241DK01 | | Inventor | | | Representative | PLOUGMANN VINGTOFT A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | | Title | Avelumab | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | 12790432.4 | | Status | Meddelt | | Pædiatrisk forlængelse | | | Udløbsdato for pædiatrisk forlængelse | |
|
|
|
|
|
